Research


Price, Value, and the Cost of Cancer Drugs

with Tito Fojo  , Lancet Oncology 17(2016), 3–5.

View abstract

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther Kim, Journal of Investment Management 14(2016), 87–101.

View abstract

Q Group Panel Discussion: Looking to the Future

with Martin Leibowitz, Robert C. Merton, Stephen A. Ross, and Jeremy Siegel, Financial Analysts Journal

View abstract

Imagine if Robo Advisers Could Do Emotions

Wall Street Journal

View abstract

Spectral Portfolio Theory

View abstract

‘Health care loans’ for Hep C cure

with David Weinstock, The Boston Globe

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

What Is An Index?

Journal of Portfolio Management 42(2016), 21–36.

View abstract

Risk and Risk Management in the Credit Card Industry

with Florentin Butaru, Qingqing Chen, Brian Clark, Sanmay Das, Akhtar Siddique, Journal of Banking and Finance 72(2016), 218–239.

View abstract

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design

with Leah Isakov and Vahid Montazerhodjat

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design